88
Participants
Start Date
October 31, 2013
Primary Completion Date
August 25, 2017
Study Completion Date
August 25, 2017
Half normal saline
2 ml/kg
Low Dose rhCC10
1.5 mg/kg study drug (rhCC10)
High dose rhCC10
5 mg/kg in 2 ml/kg
Tufts Medical Center, Boston
Brigham and Women's Hospital, Boston
Baystate Medical Center, Springfield
Brigham and Women's Hospital
OTHER
Therabron Therapeutics, Inc.
INDUSTRY
Baystate Medical Center
OTHER
Poznan University of Medical Sciences
OTHER
SP ZOZ Szpital Uniwersytecki w Krakowie Oddizat Neonatologii
UNKNOWN
Instytut Centrum Zdrowia Matki Polki Klinika Neonatologii
UNKNOWN
Tufts Medical Center
OTHER